Kolodziejczyk et al. [48] describe the antioxidative potential of curcumin (12.5–50 μg/mL) in human blood platelets and plasma treated with ONOO− (in vitro), and Manikandan et al. [49] indicate that curcumin modulates ROS production in myocardial ischemia in rats, probably by inhibition of xanthine dehydrogenase and xanthine oxidase. This evidence concerns the gene XDH and myocardial ischemia.